Login Get Started
Browse
Shares
Consumer Cyclicals
Media & Publishing
Doccheck AG
Doccheck AG logo

AJ91 - Doccheck AG Share News

€26 -1.0  -3.7%

Last Trade - 8:16am

Sector
Consumer Cyclicals
RiskRating
Adventurous
Size
Small Cap
Style
Falling Star
Market Cap £118.5m
Enterprise Value £106.5m
Revenue £33.0m
Position in Universe 691st / 1039
Quality
Value
Momentum
StockRank™
StockReport™
Tools
Compare with... Run through checklist
Accounts
Balance sheet Income statement Cashflow statement Dividend summary
Charts News Discussions AJ91 Dividends
All News
All News Reuters News Company Announcements
BRIEF-Doccheck Acquired 100% Of Medweb24 GmbH
6th Jan News
BRIEF-Doccheck Updates FY 2020 EBIT To EUR 8.5 To 10.0 Mln
15th Dec '20 News
BRIEF-DocCheck 9-Mth EBIT EUR 5.9 Mln
11th Nov '20 News
BRIEF-DocCheck Adjusts FY Forecasts
8th Oct '20 News
BRIEF-DocCheck H1 Sales Up At EUR 21.0 Million
28th Jul '20 News
BRIEF-Doccheck Q1 EBIT Down At 0.9 Million Euros
20th May '20 News
BRIEF-Doccheck Buys MediShopXL In The Netherlands
29th Apr '20 News
BRIEF-Doccheck Postpones Public Share Buyback Program
16th Mar '20 News
BRIEF-DocCheck Plans Share Buyback
5th Mar '20 News
BRIEF-DocCheck 9-Month EBIT At EUR 3.4 Mln
31st Oct '19 News
BRIEF-DocCheck H1 EBIT Of EUR 2.0 Mln
30th Jul '19 News
BRIEF-DocCheck Approves Conclusion Of Contracts With Philip Stadtmann (CFO), Thilo Kölzer (COO) And Jens Knoop (CTO)
6th Jun '19 News
BRIEF-Doccheck Q1 EBIT Up At EUR 1.0 Million
24th Apr '19 News
BRIEF-DocCheck FY EBIT At EUR 3.7 Mln
30th Jan '19 News
BRIEF-Doccheck 9-month EBIT Down At EUR 2.12 Million
31st Oct '18 News
BRIEF-DocCheck Q1 EBIT At EUR 706 Thousand
9th May '18 News
BRIEF-Doccheck FY 2017 Sales Expected To Be At 28.0 Mln Euros
24th Jan '18 News
BRIEF-DocCheck 9-mth EBIT at EUR 2.28 million
24th Oct '17 News
BRIEF-DocCheck H1 EBIT flat at 1.4 million euros
26th Jul '17 News
BRIEF-Doccheck Q1 sales up at 6.21 million euros
28th Apr '17 News
© Stockopedia 2021, Refinitiv, Share Data Services.
Youtube Instagram RSS
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.